SOPH
SOPHiA GENETICS S.A. NASDAQ Listed Jul 23, 2021$5.46
+4.20%
vs $5.24
Mkt Cap $391.3M
52w Low $2.59
92.3% of range
52w High $5.70
50d MA $5.01
200d MA $4.66
P/E (TTM)
-4.7x
EV/EBITDA
—
P/B
7.8x
Debt/Equity
1.3x
ROE
—
P/FCF
-9.6x
RSI (14)
59.50
ATR (14)
$0.32
Beta
1.04
50d MA
$5.01
200d MA
$4.66
Avg Volume
181.0K
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Rue du Centre 172 · Rolle, V8 1025 · CH
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | BMO | -0.24 | -0.28 | -17.9% | 4.10 | +0.5% | +2.9% | +0.0% | +2.6% | +0.5% | +2.5% | — |
| Nov 4, 2025 | BMO | -0.20 | -0.30 | -50.0% | 4.68 | -3.0% | -3.4% | +0.0% | +4.9% | -7.8% | -0.5% | — |
| Aug 5, 2025 | BMO | -0.21 | 0.33 | +257.1% | 3.42 | -7.9% | -7.9% | +0.0% | +1.6% | -0.6% | -5.3% | — |
| May 6, 2025 | BMO | -0.21 | -0.26 | -23.8% | 3.00 | +3.0% | +0.0% | +0.0% | -0.3% | -2.0% | +8.9% | — |
| Mar 4, 2025 | BMO | -0.23 | -0.23 | +0.0% | 3.10 | +5.5% | +0.3% | +0.0% | +0.0% | +4.2% | -0.9% | — |
| Nov 5, 2024 | BMO | -0.24 | -0.28 | -16.7% | 3.75 | -9.3% | -9.3% | +0.0% | +0.0% | +3.5% | +7.7% | — |
| Aug 6, 2024 | BMO | -0.28 | -0.23 | +17.9% | 4.06 | +0.0% | -10.1% | +0.0% | -7.9% | -3.6% | -1.5% | — |
| May 7, 2024 | BMO | -0.25 | -0.21 | +16.0% | 4.97 | +1.6% | -7.4% | +0.0% | +4.8% | -2.7% | -2.3% | — |
| Mar 5, 2024 | BMO | -0.25 | -0.37 | -48.0% | 5.60 | -8.0% | -10.5% | +0.0% | -0.4% | -5.2% | +2.5% | — |
| Nov 7, 2023 | BMO | -0.32 | -0.21 | +34.4% | 3.91 | -4.1% | +0.0% | +0.0% | -0.8% | -12.4% | -5.3% | — |
| Aug 8, 2023 | BMO | -0.29 | -0.33 | -13.8% | 3.55 | -2.5% | +1.7% | +0.0% | -6.4% | -9.2% | -2.3% | — |
| May 9, 2023 | BMO | -0.28 | -0.31 | -10.7% | 4.85 | +0.2% | -4.5% | +0.0% | +0.0% | -2.6% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 15 | BTIG | Maintains | Buy → Buy | — | $4.96 | $4.96 | +0.0% | +2.2% | +1.0% | +3.1% | -1.7% | -1.3% |
| Jan 26 | Guggenheim | Maintains | Buy → Buy | — | $5.36 | $5.36 | +0.0% | -0.7% | -1.3% | +0.0% | -1.5% | +1.5% |
| Nov 10 | BTIG | Maintains | Buy → Buy | — | $4.37 | $4.37 | +0.0% | -0.5% | +6.2% | -6.5% | +1.4% | -1.6% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $4.06 | $4.06 | +0.0% | -10.1% | -7.9% | -3.6% | -1.5% | +6.3% |
| Mar 6 | BTIG | Maintains | Buy → Buy | — | $5.60 | $5.15 | -8.0% | -10.5% | -0.4% | -5.2% | +2.5% | -3.9% |
| Mar 6 | RBC Capital | Maintains | Outperform → Outperform | — | $5.60 | $5.15 | -8.0% | -10.5% | -0.4% | -5.2% | +2.5% | -3.9% |
| Jan 12 | RBC Capital | Maintains | Outperform → Outperform | — | $5.50 | $5.46 | -0.7% | -4.9% | -12.6% | +0.4% | -1.7% | -0.2% |
| May 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $4.85 | $4.86 | +0.2% | -4.5% | +0.0% | -2.6% | -1.1% | -5.2% |
| May 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.85 | $4.86 | +0.2% | -4.5% | +0.0% | -2.6% | -1.1% | -5.2% |
| Mar 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $2.53 | $2.60 | +2.8% | +21.7% | +7.8% | +4.2% | +4.9% | +37.5% |
| Jan 3 | BTIG | Maintains | Buy → Buy | — | $2.06 | $2.19 | +6.3% | +9.2% | -2.2% | -1.8% | -8.3% | +13.1% |
| Nov 23 | Credit Suisse | Maintains | Neutral → Neutral | — | $2.00 | $1.96 | -2.0% | +0.0% | +4.0% | -2.4% | +7.4% | +6.0% |
| Nov 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $1.84 | $1.76 | -4.3% | -7.1% | +17.0% | +14.0% | -10.5% | +0.5% |
| Aug 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.79 | $5.00 | +4.4% | +2.3% | +3.1% | -5.0% | -6.2% | -1.1% |
| May 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.91 | $5.00 | +1.8% | +6.5% | -5.2% | -3.0% | +0.2% | +3.3% |
| Mar 16 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.21 | $8.20 | -0.1% | +2.7% | +2.6% | -1.3% | -0.9% | -1.5% |
| Feb 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $11.59 | $11.73 | +1.2% | +5.1% | +0.9% | -1.1% | -4.1% | +2.9% |
| Aug 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | JP Morgan | Maintains | Overweight → Overweight | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | Credit Suisse | Maintains | Outperform → Outperform | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | TD Cowen | Maintains | Outperform → Outperform | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Xu ZhenyuOff | Chief Scientific Officer | Sell | 4,000 | $5.01 | $20K | 622,280 | +4.20% | — |
| Jun 12, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $4.95 | $25K | 245,780 | -1.60% | — |
| Jun 10, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 8,500 | $5.24 | $45K | 3,620,995 | -6.15% | +4.20% |
| Jun 5, 2026 | CARDOZA GEORGEOff | Chief Financial Officer | Buy | 20,000 | $4.95 | $99K | 311,458 | +5.60% | -6.15% |
| May 26, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $4.95 | $25K | 250,780 | -1.00% | +5.60% |
| May 19, 2026 | Muken RossOff | President | Sell | 761 | $4.60 | $4K | 680,911 | +3.70% | +0.00% |
| May 19, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 608 | $4.61 | $3K | 255,780 | +3.70% | +0.00% |
| May 19, 2026 | Xu ZhenyuOff | Chief Scientific Officer | Sell | 608 | $4.60 | $3K | 626,280 | +3.70% | +0.00% |
| May 19, 2026 | Puylaert KevinOff | Chief Sales Officer | Sell | 33 | $4.54 | $150 | 148,164 | +3.70% | +0.00% |
| May 19, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 4,486 | $4.60 | $21K | 3,629,495 | +3.70% | +0.00% |
| May 19, 2026 | Van Well DaanOff | Chief Legal Officer | Sell | 684 | $4.60 | $3K | 345,052 | +3.70% | +0.00% |
| May 19, 2026 | Valente ManuelaOff | Chief People Officer | Sell | 380 | $4.60 | $2K | 214,691 | +3.70% | +0.00% |
| May 13, 2026 | Xu ZhenyuOff | Chief Scientific Officer | Sell | 4,000 | $4.54 | $18K | 626,888 | -2.32% | +3.70% |
| May 12, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $4.67 | $23K | 256,388 | +5.10% | +4.06% |
| May 12, 2026 | HIBBS KATHY LDir | — | Sell | 7,508 | $4.67 | $35K | 89,768 | +5.10% | +4.06% |
| May 11, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 8,500 | $5.09 | $43K | 3,633,981 | -2.59% | -0.21% |
| Apr 27, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $4.82 | $24K | 261,388 | +5.60% | -4.16% |
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Generation Investment Management Llp | 6,789,560 | $34M | — | Mar 2026 |
| 2 | Akre Capital Management Llc | 3,719,140 | $18M | — | Mar 2026 |
| 3 | Banque Pictet & Cie Sa | 2,208,280 | $11M | — | Mar 2026 |
| 4 | Soleus Capital Management, L.p. | 1,850,000 | $9M | New | Mar 2026 |
| 5 | Alta Wealth Advisors Llc | 1,409,160 | $7M | — | Mar 2026 |
| 6 | Principal Financial Group Inc | 1,399,442 | $7M | Added | Dec 2025 |
| 7 | Essex Investment Management Co Llc | 692,809 | $3M | New | Mar 2026 |
| 8 | Ensign Peak Advisors, Inc | 444,954 | $2M | Added | Mar 2026 |
| 9 | Archon Capital Management Llc | 441,413 | $2M | — | Mar 2026 |
| 10 | Hodges Capital Management Inc. | 435,836 | $2M | New | Mar 2026 |
| 11 | Sei Investments Co | 357,888 | $2M | New | Mar 2026 |
| 12 | Legato Capital Management Llc | 216,341 | $1M | New | Mar 2026 |
| 13 | Rathbones Group Plc | 149,133 | $738K | Reduced | Mar 2026 |
| 14 | Ubs Group Ag | 92,226 | $457K | Added | Mar 2026 |
| 15 | Morgan Stanley | 96,094 | $449K | Added | Dec 2025 |
| 16 | Renaissance Technologies Llc | 59,800 | $296K | Reduced | Mar 2026 |
| 17 | Silverberg Bernstein Capital Management Llc | 51,970 | $257K | Added | Mar 2026 |
| 18 | Green Alpha Advisors, Llc | 42,952 | $213K | Reduced | Mar 2026 |
| 19 | Pathstone Holdings, Llc | 31,465 | $156K | Reduced | Mar 2026 |
| 20 | Franklin Resources Inc | 21,563 | $107K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 2
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | SmallCap Fund | 689,000 | $4M | Jan 2026 |
| 2 | NORTH SQUARE KENNEDY MICROCAP FUND | 25,747 | $116K | Feb 2026 |
Valuation
Market Cap
$391.3M
Enterprise Value
$346.2M
P/E (TTM)
-4.67x
Forward P/E
—
PEG Ratio
-0.17x
P/B
7.82x
P/S
4.77x
P/FCF
-9.56x
EV/EBITDA
—
Shares Out
67.5M
Financials (TTM)
Revenue
$77.3M
Net Income
-$79.0M
EBITDA
-$61.4M
Free Cash Flow
-$38.6M
Op Cash Flow
-$38.0M
EPS Basic
$-1.17
EPS Diluted
$-1.17
EPS Forward
$-0.85
Gross Margin
61.9%
Op Margin
-91.8%
Net Margin
-102.2%
Balance Sheet
Total Assets
$163.5M
Total Liab.
$116.3M
Total Equity
$47.1M
Cash
$70.3M
LT Debt
$47.7M
Book Value/Sh
$0.70
Debt/Equity
1.34x
Current Ratio
1.96
Quick Ratio
1.84
Returns & Growth
ROE
—
ROA
—
ROIC
-61.3%
Rev Growth YoY
+18.6%
EPS Growth YoY
-23.2%
Price Returns
2W
+6.5%
1M
-3.3%
3M
+12.2%
6M
+2.6%
12M
+68.3%
Technicals
52W High
$5.70
52W Low
$2.59
50d MA
$5.01
200d MA
$4.66
RSI (14)
59.50
ATR (14)
$0.32
Beta
1.04
Avg Volume
181K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$7.50
High
$8.00
Low
$7.00
Median
$7.50
Data updated apr 27, 2026 2:27am
· Source: financialmodelingprep.com